Sintilimab and Bevacizumab Combined With Radiotherapy for Advanced Hepatocellular Carcinoma

NCT05010434 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: Sintilimab and Bevacizumab Combined with Radiotherapy

Sponsor

Sun Yat-sen University

Collaborators

[object Object]